MetaCap

Arcturus Therapeutics Holdings Inc. Company Profile

NASDAQ: ARCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.45-0.15 (-1.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arcturus Therapeutics at a glance

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA, Israel. Arcturus Therapeutics is led by Mr. Joseph E. Payne M.Sc. and employs about 106 people. The company's shares have traded publicly since 2013.

At a market capitalization of $214.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001768224, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Arcturus Therapeutics do?

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Arcturus Therapeutics Holdings Inc.
Ticker
NASDAQ: ARCT
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Joseph E. Payne M.Sc.
Employees
106
Headquarters
10285 Science Center Drive, San Diego, CA, Israel
Phone
858 900 2660
IPO year
2013
Market cap
$214.73M
SEC CIK
0001768224
Latest annual report
10-K · Mar 3, 2026

Companies similar to Arcturus Therapeutics

ARCT peer companies
CompanyPrice% ChgMarket capCompare
PYXSPyxis Oncology Inc.1.81+7.74%$216.49Mvs ARCT
KROSKeros Therapeutics Inc.11.08-2.72%$217.44Mvs ARCT
RCKTRocket Pharmaceuticals Inc.1.95-7.58%$217.74Mvs ARCT
IMRXImmuneering Corporation Class A3.38-2.03%$218.90Mvs ARCT
CYPHCypherpunk Technologies Inc.1.41-18.02%$210.15Mvs ARCT
VNDAVanda Pharmaceuticals Inc.3.45-6.13%$208.32Mvs ARCT
ENTAEnanta Pharmaceuticals Inc.7.62-4.51%$222.19Mvs ARCT
FTHFaeth Therapeutics Inc.7.88-9.32%$203.65Mvs ARCT

Related